These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19266466)

  • 1. [Age-related macular degeneration (AMD)].
    Michels S; Kurz-Levin M
    Ther Umsch; 2009 Mar; 66(3):189-95. PubMed ID: 19266466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related macular degeneration.
    Cheung LK; Eaton A
    Pharmacotherapy; 2013 Aug; 33(8):838-55. PubMed ID: 23580402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD.
    Kloeckener-Gruissem B; Barthelmes D; Labs S; Schindler C; Kurz-Levin M; Michels S; Fleischhauer J; Berger W; Sutter F; Menghini M
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4694-702. PubMed ID: 21282580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapeutic aspects in age-related macular degeneration].
    Adán A; Casaroli-Marano RP
    Med Clin (Barc); 2007 Nov; 129(17):658-9. PubMed ID: 18005633
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M; Barbazetto IA; Freund KB
    Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
    ; Chakravarthy U; Adamis AP; Cunningham ET; Goldbaum M; Guyer DR; Katz B; Patel M
    Ophthalmology; 2006 Sep; 113(9):1508.e1-25. PubMed ID: 16828500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related macular degeneration].
    Parier V; Soubrane G
    Rev Med Interne; 2008 Mar; 29(3):215-23. PubMed ID: 18262310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subretinal neovascular membrane in age-related macular degeneration].
    Budzinskaia MV; Gurova IV
    Vestn Oftalmol; 2006; 122(4):49-54. PubMed ID: 16927789
    [No Abstract]   [Full Text] [Related]  

  • 9. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.
    van Wijngaarden P; Qureshi SH
    Clin Exp Optom; 2008 Sep; 91(5):427-37. PubMed ID: 18637105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegaptanib for the treatment of age-related macular degeneration.
    Zhou B; Wang B
    Exp Eye Res; 2006 Sep; 83(3):615-9. PubMed ID: 16678158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy.
    Chae B; Jung JJ; Mrejen S; Gallego-Pinazo R; Yannuzzi NA; Patel SN; Chen CY; Marsiglia M; Boddu S; Freund KB
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5040-7. PubMed ID: 26237196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction to the topic: anti-VEGF therapy in the management of AMD].
    Meyer CH
    Ophthalmologe; 2008 Feb; 105(2):123-4. PubMed ID: 18256843
    [No Abstract]   [Full Text] [Related]  

  • 14. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Macular Degeneration.
    Mehta S
    Prim Care; 2015 Sep; 42(3):377-91. PubMed ID: 26319344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
    Rush RB; Rush SW; Aragon AV; Ysasaga JE
    Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
    Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
    Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in age-related macular degeneration: a review.
    Al-Zamil WM; Yassin SA
    Clin Interv Aging; 2017; 12():1313-1330. PubMed ID: 28860733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
    Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.